WINNIPEG, March 12, 2013 /CNW/ - IMRIS Inc. ("IMRIS" or the "Company")
(NASDAQ: IMRS; TSX: IM) today announced that it has commenced an
underwritten public offering of its common shares. The offering is
being conducted in the United States pursuant to the Company's
effective shelf registration statement filed with the U.S. Securities
and Exchange Commission (the "SEC") and in Canada pursuant to a final
short form base shelf prospectus filed with the securities regulatory
authorities in each of the provinces and territories of Canada, other
than Quebec. The number of common shares to be issued and the price of
each common share will be determined at the time of pricing the
proposed offering.
Canaccord Genuity is acting as sole book-running manager for the
proposed offering. The Company expects to grant the underwriter a
30-day option to purchase up to an additional 15 percent of the number
of common shares sold pursuant to the public offering solely to cover
over-allotments, if any. The proposed offering is subject to customary
conditions, including the approval of the Toronto Stock Exchange and
The NASDAQ Stock Market, and there can be no assurance as to whether or
when the proposed offering may be completed, or as to the actual size
or terms of the offering.
The proposed offering will be made only by means of the prospectus
supplement and the accompanying short form base shelf prospectus. When
available, copies of the preliminary prospectus supplement and the
accompanying short form base shelf prospectus may be obtained upon
request by contacting Canaccord Genuity Inc., Attention: Syndicate
Department, 99 High Street, 12th Floor, Boston, Massachusetts 02110, or
by telephone at (617) 371-3900. Electronic copies of the preliminary
prospectus supplement and the accompanying short form base shelf
prospectus will also be available free of charge at www.sedar.com and
www.sec.gov, respectively.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy the securities described herein, nor
shall there be any sale of these securities in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
jurisdiction.
About IMRIS
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
intraoperative vision to clinicians to assist in decision making and
enhance precision in treatment. VISIUS Surgical Theatres serve the
neurosurgical, cardiovascular and cerebrovascular markets and have been
selected by leading medical institutions around the world.
For more information, visit www.imris.com
Forward-Looking Statements
This press release may contain or refer to certain information that may
constitute "forward-looking information" and "forward-looking
statements" within the meaning of applicable Canadian and United States
securities laws. These statements are based upon assumptions that the
proposed offering will be successfully completed on the terms described
above. There can be no assurance that IMRIS will complete the proposed
offering. All statements relating to plans, strategies, projections of
results of specific activities or investments, and other statements
that are not descriptions of historical facts may be forward-looking
statements. Forward-looking statements and information are inherently
subject to risks and uncertainties, and actual results could differ
materially from those currently anticipated due to a number of factors,
which include, but are not limited to, operational risks, the effects
of general economic conditions, changing foreign exchange rates and
actions by government authorities, uncertainties associated with legal
proceedings and negotiations, industry supply levels, competitive
pricing pressures and other risks and uncertainties disclosed under the
heading "Risk Factors" in the Company's short form base shelf
prospectus and the registration statement on Form F-10 related to the
proposed offering, the Company's Annual Information Form in respect of
the year ended December 31, 2012 and the risks and uncertainties
disclosed in the Management's Discussion and Analysis for the year
ended December 31, 2012. Forward-looking statements and information may
be identified by terms such as "may", "will", "should", "continue",
"expect", "anticipate", "estimate", "believe", "intend", "plan" or
"project", or similar terms or the negatives of these terms. Although
we believe that the expectations reflected in the forward-looking
statements and information are reasonable, we cannot guarantee future
results, levels of activity, performance, or achievements. The
Company's forward-looking statements and information reflect the
beliefs, opinions and projections on the date the statements are made.
The Company assumes no obligation to update forward-looking information
should circumstances or management's estimates or opinions change,
except as required by law.
SOURCE: IMRIS Inc.
